OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Concomitant PIK3CD and TNFRSF9 deficiencies cause chronic active Epstein-Barr virus infection of T cells
Rémy Rodriguez, Benjamin Fournier, Débora Jorge Cordeiro, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 12, pp. 2800-2818
Open Access | Times Cited: 69

Showing 26-50 of 69 citing articles:

Novel target and treatment agents for natural killer/T-cell lymphoma
Xiao‐Peng Tian, Yi Cao, Jun Cai, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8

Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective
Lucinda J. Berglund
Journal of Clinical Immunology (2023) Vol. 44, Iss. 1
Open Access | Times Cited: 8

Epstein–Barr Virus in Inborn Immunodeficiency—More Than Infection
Ciro N. R. Lino, Sujal Ghosh
Cancers (2021) Vol. 13, Iss. 19, pp. 4752-4752
Open Access | Times Cited: 20

Updating targets for natural killer/T-cell lymphoma immunotherapy
Weili Xue, Mingzhi Zhang
Cancer Biology and Medicine (2021) Vol. 18, Iss. 1, pp. 52-62
Open Access | Times Cited: 18

Single-cell immune checkpoint landscape of PBMCs stimulated with Candida albicans
Weiwei Deng, Zhen Su, Panpan Liang, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 1272-1283
Open Access | Times Cited: 18

Clinical and genetic characterization of Epstein-Barr virus–associated T/NK-cell lymphoproliferative diseases
Hui Luo, Dan Liu, Wenbing Liu, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 1096-1109
Closed Access | Times Cited: 13

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies
Javier Glez‐Vaz, Arantza Azpilikueta, Irene Olivera, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e003532-e003532
Open Access | Times Cited: 12

Inherited TNFSF9 deficiency causes broad Epstein–Barr virus infection with EBV+ smooth muscle tumors
Benjamin Fournier, Akihiro Hoshino, Julie Bruneau, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 7
Open Access | Times Cited: 12

Cytotoxicity in Epstein Barr virus specific immune control
Christian Münz
Current Opinion in Virology (2020) Vol. 46, pp. 1-8
Open Access | Times Cited: 18

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
Wiyada Wongwiwat, Benjamin Fournier, Irene Bassano, et al.
Journal of Virology (2022) Vol. 96, Iss. 12
Open Access | Times Cited: 10

Homeostatic and pathogenic roles of PI3Kδ in the human immune system
Georgios Sogkas, Ignatius Ryan Adriawan, Natalia Dubrowinskaja, et al.
Advances in immunology (2020), pp. 109-137
Closed Access | Times Cited: 15

Genetic predisposition to lymphomas: Overview of rare syndromes and inherited familial variants
Bartosz Szmyd, Wojciech Młynarski, Agata Pastorczak
Mutation Research/Reviews in Mutation Research (2021) Vol. 788, pp. 108386-108386
Closed Access | Times Cited: 12

The role of trogocytosis in immune surveillance of Hodgkin lymphoma
Qun Zeng, Herbert Schwarz
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 12

Outcome of L-DEP regimen for treatment of pediatric chronic active Epstein–Barr virus infection
Honghao Ma, Ping Zhang, Ang Wei, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 11

Natural killer cell responses to human oncogenic γ-herpesvirus infections
Christian Münz
Seminars in Immunology (2022) Vol. 60, pp. 101652-101652
Open Access | Times Cited: 8

Loss-of-phosphorylation of IKZF1 results in gain-of-function associated with immune dysregulation
Akihiro Hoshino, Benoît Heid Picard, Sophia Polychronopoulou, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 1, pp. 229-236.e2
Open Access | Times Cited: 1

Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge
Prabal Barman, Suprit Basu, Taru Goyal, et al.
Expert Review of Clinical Immunology (2024) Vol. 20, Iss. 11, pp. 1331-1346
Closed Access | Times Cited: 1

Pediatric lymphoproliferative disorders associated with inborn errors of immunity
Jinjun Cheng, Blachy J. Dávila Saldaña, Shanmuganathan Chandrakasan, et al.
Clinical Immunology (2024) Vol. 266, pp. 110332-110332
Closed Access | Times Cited: 1

Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection
Christian Münz
Biomolecules (2021) Vol. 12, Iss. 1, pp. 38-38
Open Access | Times Cited: 9

Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications
Tina Nguyen, Elissa K. Deenick, Stuart G. Tangye
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 8, pp. 905-914
Closed Access | Times Cited: 8

Rescuing the cytolytic function of APDS1 patient T cells via TALEN-mediated PIK3CD gene correction
Lucie Poggi, Loïc Chentout, Sabrina Lizot, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 31, pp. 101133-101133
Open Access | Times Cited: 3

Scroll to top